Surface immobilization of kanamycin-chitosan nanoparticles on polyurethane ureteral stents to prevent bacterial adhesion

References

• Arulmozhi V, Pandian K, Mirunalini S. 2013. Ellagic acid encapsulated chitosan nanoparticles for drug delivery system in human oral cancer cell line (KB). Colloids Surf B Biointerfaces. 110:313–320. doi:10.1016/j.colsurfb.2013.03.039.
   PubMed Web of Science ®Google Scholar
• Avadi MR, Sadeghi AMM, Mohammadpour N, Abedin S, Atyabi F, Dinarvand R, Rafiee-Tehrani M. 2010. Preparation and characterization of insulin nanoparticles using chitosan and Arabic gum with ionic gelation method. Nanomedicine. 6:58–63. doi:10.1016/j.nano.2009.04.007.
   PubMed Web of Science ®Google Scholar
• Brooks T, Keevil CW. 1997. A simple artificial urine for the growth of urinary pathogens. Lett Appl Microbiol. 24:203–206. doi:10.1046/j.1472-765X.1997.00378.x.
   PubMed Web of Science ®Google Scholar
• Cadieux PA, Chew BH, Nott L, Seney S, Elwood CN, Wignall GR, Goneau LW, Denstedt JD. 2009. Use of triclosan-eluting ureteral stents in patients with long-term stents. J Endourol. 23:1187–1194. doi:10.1089/end.2008.0437.
   PubMed Web of Science ®Google Scholar
• Cauda F, Cauda V, Fiori C, Onida B, Garrone E. 2008. Heparin coating on ureteral double J stents prevents encrustations: an in vivo case study. J Endourol. 22:465–472. doi:10.1089/end.2007.0218.
   PubMed Web of Science ®Google Scholar
• Chen G, Wang Z, Wang H, Zhao X, Hu J, Wang S, Zhang S. 2012. Effects of tetrahedral amorphous carbon film deposited on dental cobalt–chromium alloys on bacterial adhesion. Surf Coat Tech. 206:3386–3392. doi:10.1016/j.surfcoat.2012.01.059.
   Web of Science ®Google Scholar
• Chutipongtanate S, Thongboonkerd V 2010. Anal Biochem 402:110–112 v 2012. doi:10.1016/j.ab.2010.03.031.
   PubMed Web of Science ®Google Scholar
• Da Silva RM, López-Pérez PM, Elvira C, Mano JF, Román JS, Reis RL. 2008. Poly(N-isopropylacrylamide) surface-grafted chitosan membranes as a new substrate for cell sheet engineering and manipulation. Biotechnol Bioeng. 101:1321–1331. doi:10.1002/bit.22004.
   PubMed Web of Science ®Google Scholar
• Fan W, Yan W, Xu Z, Ni H. 2012. Formation mechanism of monodisperse, low molecular weight chitosan nanoparticles by ionic gelation technique. Colloids Surf B Biointerfaces. 90:21–27. doi:10.1016/j.colsurfb.2011.09.042.
   PubMed Web of Science ®Google Scholar
• Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. 2015. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. 13:269–284. doi:10.1038/nrmicro3432.
   PubMed Web of Science ®Google Scholar
• Gnanasundaram S, Ranganathan M, Das BN, Mandal AB. 2013. Surface modified and medicated polyurethane materials capable of controlling microorganisms causing foot skin infection in athletes. Colloids Surf B Biointerfaces. 102:139–145. doi:10.1016/j.colsurfb.2012.07.024.
   PubMed Web of Science ®Google Scholar
• Gultekinoglu M, Tunc Sarisozen Y, Erdogdu C, Sagiroglu M, Aksoy EA, Oh YJ, Hinterdorfer P, Ulubayram K. 2015. Designing of dynamic polyethyleneimine (PEI) brushes on polyurethane (PU) ureteral stents to prevent infections. Acta Biomater. 21:44–54. doi:10.1016/j.actbio.2015.03.037.
   PubMed Web of Science ®Google Scholar
• Hasirci N, Ayse Aksoy E. 2007. Synthesis and modifications of polyurethanes for biomedical purposes. High Perform Polym. 19:621–637. doi:10.1177/0954008307081203.
   Web of Science ®Google Scholar
• Jia M, Li Y, Yang X, Huang Y, Wu H, Huang Y, Lin J, Li Y, Hou Z, Zhang Q. 2014. Development of both methotrexate and mitomycin C loaded pegylated chitosan nanoparticles for targeted drug codelivery and synergistic anticancer effect. ACS Appl Mater Interfaces. 6:11413–11423. doi:10.1021/am501932s.
   PubMed Web of Science ®Google Scholar
• Kara F, Aksoy EA, Yuksekdag Z, Hasirci N, Aksoy S. 2014. Synthesis and surface modification of polyurethanes with chitosan for antibacterial properties. Carbohydr Polym. 112:39–47. doi:10.1016/j.carbpol.2014.05.019.
   PubMed Web of Science ®Google Scholar
• Kleiner LW, Wright JC, Wang Y. 2014. Evolution of implantable and insertable drug delivery systems. J Control Release. 181:1–10. doi:10.1016/j.jconrel.2014.02.006.
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, Buri P, Peppas NA. 1983. Mechanisms of solute release from porous hydrophilic polymers. Int J Pharm. 15:25–35. doi:10.1016/0378-5173(83)90064-9.
   Web of Science ®Google Scholar
• Lange D, Bidnur S, Hoag N, Chew BH. 2015. Ureteral stent-associated complications—where we are and where we are going. Nat Rev Urol. 12:17–25. doi:10.1038/nrurol.2014.340.
   PubMed Web of Science ®Google Scholar
• Lange D, Chew BH. 2009. Update on ureteral stent technology. Ther Adv Urol. 1:143–148. doi:10.1177/1756287209341306.
   PubMedGoogle Scholar
• Lange D, Elwood CN, Choi K, Hendlin K, Monga M, Chew BH. 2009. Uropathogen interaction with the surface of urological stents using different surface properties. J Urol. 182:1194–1200. doi:10.1016/j.juro.2009.05.008.
   PubMed Web of Science ®Google Scholar
• Lo J, Lange D, Chew BH. 2014. Ureteral stents and Foley catheters-associated urinary tract infections: the role of coatings and materials in infection prevention. Antibiotics. 3:87–97. doi:10.3390/antibiotics3010087.
   Google Scholar
• Ma X, Oyamada S, Gao F, Wu T, Robich MP, Wu H, Wang X, Buchholz B, McCarthy S, Gu Z, et al. 2011. Paclitaxel/sirolimus combination coated drug-eluting stent: In vitro and in vivo drug release studies. J Pharm Biomed Anal. 54:807–811. doi:10.1016/j.jpba.2010.10.027.
   PubMed Web of Science ®Google Scholar
• Noimark S, Dunnill CW, Wilson M, Parkin IP. 2009. The role of surfaces in catheter-associated infections. Chem Soc Rev. 38:3435–3448. doi:10.1039/b908260c.
   PubMed Web of Science ®Google Scholar
• Nowatzki PJ, Koepsel RR, Stoodley P, Min K, Harper A, Murata H, Donfack J, Hortelano ER, Ehrlich GD, Russell AJ. 2012. Salicylic acid-releasing polyurethane acrylate polymers as anti-biofilm urological catheter coatings. Acta Biomater. 8:1869–1880. doi:10.1016/j.actbio.2012.01.032.
   PubMed Web of Science ®Google Scholar
• Pandiyaraj KN, Ferraria AM, Rego AMBD, Deshmukh RR, Su P-G, Halleluyah JM, et al. 2015. Low-pressure plasma enhanced immobilization of chitosan on low-density polyethylene for bio-medical applications. Appl Surf Sci. 328:1–12.
   Web of Science ®Google Scholar
• Rabea EI, Badawy ME-t, Stevens CV, Smagghe G, Steurbaut W. 2003. Chitosan as antimicrobial agent: applications and mode of action. Biomacromolecules. 4:1457–1465. doi:10.1021/bm034130m.
   PubMed Web of Science ®Google Scholar
• Riedl CR, Witkowski M, Plas E, Pflueger H. 2002. Heparin coating reduces encrustation of ureteral stents: a preliminary report. Int J Antimicrob Agents. 19:507–510. doi:10.1016/S0924-8579(02)00097-3.
   PubMed Web of Science ®Google Scholar
• Ritger PL, Peppas NA. 1987. A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs. J Control Release. 5:23–36. doi:10.1016/0168-3659(87)90034-4.
   Google Scholar
• Pickard R, Lam T, MacLennan G, Starr K, Kilonzo M, McPherson G, Gillies K, McDonald A, Walton K, Buckley B, et al. 2012. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 380:1927–1935. doi:10.1016/S0140-6736(12)61380-4.
   PubMed Web of Science ®Google Scholar
• Roy N, Waingankar S, Aggarwal G. 2012. Assessment of bio-safety of low-cost polyurethane urologic stents used in developing countries. Indian J Urol. 28:184–188. doi:10.4103/0970-1591.98462.
   PubMedGoogle Scholar
• Sanyakamdhorn S, Agudelo D, Tajmir-Riahi HA. 2013. Encapsulation of antitumor drug doxorubicin and its analogue by chitosan nanoparticles. Biomacromolecules. 14:557–563. doi:10.1021/bm3018577.
   PubMed Web of Science ®Google Scholar
• Sarwar A, Katas H, Zin NM. 2014. Antibacterial effects of chitosan–tripolyphosphate nanoparticles: impact of particle size molecular weight. J Nanopart Res. 16:2517–2529. doi:10.1007/s11051-014-2517-9.
   Web of Science ®Google Scholar
• Shi Z, Neoh KG, Kang ET, Wang W. 2006. Antibacterial and mechanical properties of bone cement impregnated with chitosan nanoparticles. Biomaterials. 27:2440–2449. doi:10.1016/j.biomaterials.2005.11.036.
   PubMed Web of Science ®Google Scholar
• Vartiainen J, Rättö M, Tapper U, Paulussen S, Hurme E. 2005. Surface modification of atmospheric plasma activated BOPP by immobilizing chitosan. Polym Bull. 54:343–352. doi:10.1007/s00289-005-0382-5.
   Web of Science ®Google Scholar
• Velusamy P, Chia-Hung S, Shritama A, Kumar GV, Jeyanthi V, Pandian K. 2016. Synthesis of oleic acid coated iron oxide nanoparticles and its role in anti-biofilm activity against clinical isolates of bacterial pathogens. J Taiwan Inst Chem Eng. 59:450–456. doi:10.1016/j.jtice.2015.07.018.
   Web of Science ®Google Scholar
• Wang JJ, Zeng ZW, Xiao RZ, Xie T, Zhou GL, Zhan XR, Wang SL. 2011. Recent advances of chitosan nanoparticles as drug carriers. Int J Nanomed. 6:765–774. doi:10.2147/IJN.S17296.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hong Q, Chen Y, Lian X, Xiong Y. 2012. Surface properties of polyurethanes modified by bioactive polysaccharide-based polyelectrolyte multilayers. Colloids Surf B Biointerfaces. 100:77–83. doi:10.1016/j.colsurfb.2012.05.030.
   PubMed Web of Science ®Google Scholar
• Yalinca Z, Yilmaz E, Taneri B, Bullici FT. 2013. A comparative study on antibacterial activities of chitosan based products and their combinations with gentamicin against S. epidermidis and E. coli. Polym Bull. 70:3407–3423. doi:10.1007/s00289-013-1030-0.
   Web of Science ®Google Scholar
• Zhang A, Mu H, Zhang W, Cui G, Zhu J, Duan J. 2013. Chitosan coupling makes microbial biofilms susceptible to antibiotics. Sci Rep. 3:3364. doi:10.1038/srep03364.
   PubMed Web of Science ®Google Scholar